Surgical implantation of steroids with antiangiogenic characteristics for treating neovascular age-related macular degeneration-Reference-Cited by-同舟云学术

Surgical implantation of steroids with antiangiogenic characteristics for treating neovascular age-related macular degeneration

Published:2013-01-31 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Geltzer Arthur¹,Turalba Angela²,Vedula Satyanarayana S³

Affiliation:

1. Brown University; 389 Benefit Street Providence Rhode Island USA 02906

2. Massachusetts Eye and Ear Infirmary; 243 Charles Street Boston Massachusetts USA 02114

3. Johns Hopkins Bloomberg School of Public Health; Department of Epidemiology; 615 N. Wolfe Street, W5010 Baltimore Maryland USA 21205

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD005022.pub3/fullpdf

Reference49 articles.

1. Safety of posterior juxtascleral depot administration of the angiostatic cortisone anecortave acetate for treatment of subfoveal choroidal neovascularization in patients with age-related macular degeneration;Augustin;Graefe's Archive for Clinical and Experimental Ophthalmology,2005

2. Regillo CD D'Amico DJ Mieler WF Beasley CH Schneebaum C Safety of anecortave acetate administered as posterior juxtascleral injection in patients with subfoveal choroidal neovascularization American Academy of Ophthalmology 2002 282

3. Anecortave acetate for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration;Schmidt-Erfurth;European Journal of Ophthalmology,2005

4. Anecortave acetate as monotherapy for the treatment of subfoveal lesions in patients with exudative age-related macular degeneration (AMD) - Interim (month 6) analysis of clinical safety and efficacy;The Anecortave Acetate Clinical Study Group;Retina,2003

5. Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration - twelve-month clinical outcomes;The Anecortave Acetate Clinical Study Group;Ophthalmology,2003

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Photosensitizing Herbs as Potential Therapeutics: A Prospective Insights into their Mechanisms for the Development of Novel Drug Leads in War with Cancer and Other Human Diseases;Open Access Macedonian Journal of Medical Sciences;2024-04-25

2. Intravitreal Dexamethasone as a Rescue for Anti-Vascular Endothelial Growth Factor Therapy in Neovascular Age-Related Macular Degeneration with Persistent Disease Activity and High Treatment Demand;Journal of Ocular Pharmacology and Therapeutics;2023-12-20

3. The Role of Inflammation in Age-Related Macular Degeneration: Updates and Possible Therapeutic Approaches;Asia-Pacific Journal of Ophthalmology;2022-10-21

4. Anti-vascular endothelial growth factor therapy for age-related macular degeneration: a systematic review and network meta-analysis;Systematic Reviews;2021-12

5. Altered plasma cytokine levels in acute and chronic central serous chorioretinopathy;Acta Ophthalmologica;2020-07-23